Header Logo
Last Name

You can now add alternative names! Click here to add other names that you've published under.

Malek Al-Hawwas

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Cardiology
Address324 UAMS Campus Dr.
Mail Slot # 532
Little Rock AR 72205
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    NN6018-4758     (AL-HAWWAS, MALEK)Sep 8, 2022 - Sep 7, 2032
    Novo Nordisk
    ZEUS - Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation (IRB 263268)
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Miller K, Biscaglia S, Hakeem A. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure. JACC Cardiovasc Interv. 2022 11 14; 15(21):2192-2202. PMID: 36357023.
      View in: PubMed
    2. Salah HM, Almaddah N, Xu J, Al-Hawwas M, Agarwal SK, Uretsky BF, Dhar G, Al'Aref SJ. Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies. Curr Probl Cardiol. 2023 Jul; 48(7):101155. PMID: 35192871.
      View in: PubMed
    3. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022 02 05; 21(1):20. PMID: 35123480.
      View in: PubMed
    4. Vallurupalli S, Salehi N, Agarwal S, Hasan R, Hassan A, Siraj A, Madmani ME, Rafeedheen R, Ayan M, Al-Hawwas M, Hakeem A, Uretsky BF. Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention. Catheter Cardiovasc Interv. 2021 11 15; 98(6):1021-1026. PMID: 34499399.
      View in: PubMed
    5. Hakeem A, Hou L, Shah K, Agarwal SK, Almomani A, Edupuganti M, Kasula S, Pothineni NV, Al-Hawwas M, Miller K, Zakir R, Ghosh B, Uretsky BF. Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry. Catheter Cardiovasc Interv. 2022 02; 99(3):714-722. PMID: 34101336.
      View in: PubMed
    6. Agarwal SK, Hakeem A, Hasan R, Ayan M, Siraj A, Madmani ME, Rafeedheen R, Salehi N, Kasula S, Hacioglu Y, Miller K, Vallurupalli S, Al-Hawwas M, Uretsky BF. Fractional Flow Reserve After Functionally Optimized Coronary Intervention Predicts Very Long-Term Outcomes. JACC Cardiovasc Interv. 2021 02 08; 14(3):355-356. PMID: 33541550.
      View in: PubMed
    7. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update. Am Heart J. 2021 03; 233:86-91. PMID: 33385359.
      View in: PubMed
    8. Salah HM, Al'Aref SJ, Khan MS, Al-Hawwas M, Vallurupalli S, Mehta JL, Mounsey JP, Greene SJ, McGuire DK, Lopes RD, Fudim M. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials. Am Heart J. 2021 02; 232:10-22. PMID: 33214130.
      View in: PubMed
    9. Hassan A, Uretsky BF, Vargas Estrada AM, Hassan R, Al-Hawwas M, Agarwal SK. Systematic review of the evaluation and management of coronary pseudoaneurysm after stent implantation. Catheter Cardiovasc Interv. 2021 07 01; 98(1):107-116. PMID: 33016651.
      View in: PubMed
    10. Ayan M, Kovelamudi S, Al-Hawwas M. Subacute stent thrombosis in a patient with COVID-19 pneumonia. Proc (Bayl Univ Med Cent). 2020 Sep 08; 34(1):175-177. PMID: 33456191.
      View in: PubMed
    11. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 02 04; 9(3):e015073. PMID: 32013707.
      View in: PubMed
    12. Kadavath S, Ayan M, Al-Hawwas M. Dynamic Systolic Compression of the Left Anterior Descending Coronary Artery as the First Clue of Postinfarction Left Ventricular Pseudoaneurysm. Can J Cardiol. 2019 10; 35(10):1419.e9-1419.e11. PMID: 31601417.
      View in: PubMed
    13. Al-Hawwas M, Tsitlakidou D, Gupta N, Iliescu C, Cilingiroglu M, Marmagkiolis K. Acute Coronary Syndrome Management in Cancer Patients. Curr Oncol Rep. 2018 08 22; 20(10):78. PMID: 30132257.
      View in: PubMed
    14. Al-Hawwas M, Marmagkiolis K, Mehta JL. The Impact of Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement on Left Ventricular Remodeling. Am J Cardiol. 2017 Oct 01; 120(7):1198-1202. PMID: 28823482.
      View in: PubMed
    15. Khan R, Al-Hawwas M, Hatem R, Azzalini L, Fortier A, Joliecoeur EM, Tanguay JF, Lavoie-L'Allier P, Ly HQ. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2016 Nov; 88(5):740-747. PMID: 26833916.
      View in: PubMed
    16. Azzalini L, Al-Hawwas M, L'Allier PL. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity. EuroIntervention. 2015 May 19; 11(1):e1-2. PMID: 25982486.
      View in: PubMed
    17. Azzalini L, Khan R, Al-Hawwas M, Hatem R, Fortier A, L'Allier PL, Ly HQ. Effect of radial-to-femoral access crossover on adverse outcomes in primary percutaneous coronary intervention. Am J Cardiol. 2014 Oct 15; 114(8):1165-73. PMID: 25260813.
      View in: PubMed
    18. Marmagkiolis K, Hakeem A, Choksi N, Al-Hawwas M, Edupuganti MM, Leesar MA, Cilingiroglu M. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Catheter Cardiovasc Interv. 2014 Oct 01; 84(4):555-64. PMID: 24740749.
      View in: PubMed
    Al-Hawwas's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Co-Authors Expand Description
    Similar People Expand Description
    Same Department Expand Description